Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tenofovir Amibufenamide（TMF）
DRUG
2 trials
Sponsors
Ruijin Hospital
, Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions
Chronic Hepatitis b
HBV Infection
Hepatitis B, Chronic
Phase 4
Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB
Active, not recruiting
NCT06743438
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Hepatitis B, Chronic
Start: 2022-03-10
End: 2029-09-30
Updated: 2024-12-19
Unknown Phase
The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT.
Active, not recruiting
NCT05797714
Ruijin Hospital
Chronic Hepatitis b, HBV Infection
Start: 2022-06-08
End: 2028-04-30
Target: 200
Updated: 2025-11-17
Related Papers
Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE Study.
2025-06-30